Magna Q2 Profit Misses Estimates, Cuts Outlook On Continued Chip Shortage; Stock Down

Magna International Inc. (MGA,MG.TO) said its second-quarter sales, adjusted EBIT and earnings per share came in well below the company's expectations due to significant production disruptions as a result of the global semiconductor chip shortage. The company reduced its fiscal 2021 guidance, largely reflecting reduction in expected global light vehicle production.

Second-quarter adjusted profit per share was $1.40 compared to a loss of $1.71 per share, a year ago. On average, 18 analysts polled by Thomson Reuters expected the company to report profit per share of $1.47, for the quarter. Analysts' estimates typically exclude special items. Adjusted EBIT was $557 million compared to a loss of $600 million, last year.

Net income attributable to Magna was $424 million compared to a loss of $647 million, last year. Profit per share was $1.40, compared to a loss of $2.17.

Sales were $9.0 billion, up 110% over the second quarter of 2020, as global light vehicle production increased 58%, largely driven by increases in North America and Europe. Analysts expected revenue of $9.37 billion, for the quarter.

For fiscal 2021, the company now expects total sales in a range of $38.0 billion to $39.5 billion, revised from prior guidance range of $40.2 billion to $41.8 billion. Net income attributable to Magna is now expected in a range of $2.0 billion to $2.2 billion, revised from prior guidance of $2.2 billion to $2.4 billion.

The Board declared a second quarter dividend of $0.43 per common share, payable on September 3, 2021 to shareholders of record as of the close of business on August 20, 2021.

Shares of Magna International were down 4% in pre-market trade on Friday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT